Compare Kokoh Inti Arebama Tbk (KOIN) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kokoh Inti Arebama Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Kokoh Inti Arebama Tbk trades at Rp78 (market cap 78.47B, 61.5K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 8.8× Kokoh Inti Arebama Tbk's market cap, and UBC Medical Indonesia Tbk. is more actively traded (635.5K versus 61.5K). Which is the better fit depends on your goals.
| KOIN | LABS | |
|---|---|---|
Market Cap | 78.47B | 691.25B |
Volume | 61.5K | 635.5K |
Lot | 615 | 6.36K |
Turnover | — | 110.15M |
Average Price | — | 173.33 |
Value | — | 110.15M |
Indicative Equilibrium Price | — | 174 |
Indicative Equilibrium Volume | — | 50 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kokoh Inti Arebama Tbk
PT Kokoh Inti Arebama Tbk (the company) was established on 6 Jul 2001 based on Notaries Deed No. 27. The Company’s articles of association has been amended several times, most recently by notarial deed No. 7 of Mr. Nanda Fauz Iwan, SH., dated Aug 30, 2007, concerning among others, the change board commission and Company’s capital structure. PT Kokoh Inti Arebama is an Indonesia-based distributor. The Company is engaged in the distribution of ceramic wall, floor and roof tiles under the brands Lacassa, KIA and Impresso. The Company also acts as a distributor for sanitary products under the brand Claytan, paint products under the brand Kansai Paint and cement products under the brand Jaya Mortar. The Company has one subsidiary namely PT Karya Makmur Kreasi Prima. Headquartered in Jakarta, Indonesia, the Company has 16 branch offices and two stock points.
Read more on KOIN →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
